{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T10:43:21Z","timestamp":1779187401909,"version":"3.51.4"},"publisher-location":"Cham","reference-count":61,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031121838","type":"print"},{"value":"9783031121845","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/7854_2021_269","type":"book-chapter","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T09:50:22Z","timestamp":1642153822000},"page":"71-92","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults"],"prefix":"10.1007","author":[{"given":"Alicia","family":"Danforth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"key":"269_CR1001","volume-title":"The use of LSD in psychotherapy: transactions of a conference on dlysergic acid diethylamide (LSD-25)","author":"HA Abramson","year":"1960","unstructured":"Abramson HA (1960) The use of LSD in psychotherapy: transactions of a conference on dlysergic acid diethylamide (LSD-25). Josiah Macy Jr. Foundation, Oxford"},{"key":"269_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/02770906709104325","volume":"5","author":"HA Abramson","year":"1967","unstructured":"Abramson HA (1967) The use of LSD (D-lysergic acid diethylamide) in the therapy of children: a brief review. J Asthma Res 5:139\u2013143","journal-title":"J Asthma Res"},{"key":"269_CR2","volume-title":"Examining the causes of autism. Cerebrum: the Dana forum on brain science","author":"DG Amaral","year":"2017","unstructured":"Amaral DG (2017) Examining the causes of autism. Cerebrum: the Dana forum on brain science. Dana Foundation"},{"key":"269_CR3","volume-title":"Recent advances in biological psychiatry","author":"L Bender","year":"1962","unstructured":"Bender L, Goldschmidt L, Sankar DS, Freedman AM (1962) Treatment of autistic schizophrenic children with LSD-25 and UML-491. In: Recent advances in biological psychiatry. Springer"},{"key":"269_CR4","first-page":"84","volume":"5","author":"L Bender","year":"1963","unstructured":"Bender L, Faretra G, Cobrinik L (1963) LSD and UML treatment of hospitalized disturbed children. Recent Adv Biol Psychiatry 5:84\u201392","journal-title":"Recent Adv Biol Psychiatry"},{"key":"269_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10803-008-0593-3","volume":"39","author":"A Ben-Sasson","year":"2009","unstructured":"Ben-Sasson A, Hen L, Fluss R, Cermak SA, Engel-Yeger B, Gal E (2009) A meta-analysis of sensory modulation symptoms in individuals with autism spectrum disorders. J Autism Dev Disord 39:1\u201311","journal-title":"J Autism Dev Disord"},{"key":"269_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1089\/aut.2020.0014","volume":"3","author":"K Bottema-Beutel","year":"2021","unstructured":"Bottema-Beutel K, Kapp SK, Lester JN, Sasson NJ, Hand BN (2021) Avoiding ableist language: suggestions for autism researchers. Autism Adulthood 3:18\u201329","journal-title":"Autism Adulthood"},{"key":"269_CR7","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1177\/1362361320922640","volume":"24","author":"J Brinkert","year":"2020","unstructured":"Brinkert J, Remington A (2020) Making sense of the perceptual capacities in autistic and non-autistic adults. Autism 24:1795\u20131804","journal-title":"Autism"},{"key":"269_CR8","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00213-014-3714-z","volume":"232","author":"RL Carhart-Harris","year":"2015","unstructured":"Carhart-Harris RL, Kaelen M, Whalley M, Bolstridge M, Feilding A, Nutt D (2015) LSD enhances suggestibility in healthy volunteers. Psychopharmacology 232:785\u2013794","journal-title":"Psychopharmacology"},{"key":"269_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13229-016-0112-x","volume":"7","author":"S Cassidy","year":"2016","unstructured":"Cassidy S, Hannant P, Tavassoli T, Allison C, Smith P, Baron-Cohen S (2016) Dyspraxia and autistic traits in adults with and without autism spectrum conditions. Mol Autism 7:1\u20136","journal-title":"Mol Autism"},{"key":"269_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.4324\/9780429322297-21","volume-title":"Neurodiversity studies: a new critical paradigm","author":"R Chapman","year":"2020","unstructured":"Chapman R (2020) Defining neurodiversity for research and practice. In: Neurodiversity studies: a new critical paradigm. Routledge, pp 218\u2013220"},{"key":"269_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1089\/cap.2018.0121","volume":"29","author":"DM Coleman","year":"2019","unstructured":"Coleman DM, Adams JB, Anderson AL, Frye RE (2019) Rating of the effectiveness of 26 psychiatric and seizure medications for autism spectrum disorder: results of a National Survey. J Child Adolesc Psychopharmacol 29:107\u2013123","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"269_CR12","volume-title":"Courage, connection, and clarity: a mixed-methods collective-case study of MDMA (ecstasy) experiences of autistic adults","author":"AL Danforth","year":"2013","unstructured":"Danforth AL (2013) Courage, connection, and clarity: a mixed-methods collective-case study of MDMA (ecstasy) experiences of autistic adults. Institute of Transpersonal Psychology"},{"key":"269_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/02791072.2019.1587116","volume":"51","author":"AL Danforth","year":"2019","unstructured":"Danforth AL (2019) Embracing neurodiversity in psychedelic science: a mixed-methods inquiry into the MDMA experiences of autistic adults. J Psychoactive Drugs 51:146\u2013154","journal-title":"J Psychoactive Drugs"},{"key":"269_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pnpbp.2015.03.011","volume":"64","author":"AL Danforth","year":"2015","unstructured":"Danforth AL, Struble CM, Klosinski B, Grob C (2015) MDMA-assisted therapy: a new treatment paradigm for autistic adults with social anxiety. Prog Neuro-Psychopharmacol Biol Psychiatry 64:237\u2013249","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"269_CR15","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1007\/s00213-018-5010-9","volume":"235","author":"AL Danforth","year":"2018","unstructured":"Danforth AL, Grob CS, Struble C, Feduccia AA, Walker N, Jerome L, Yazar-Klosinski B, Emerson A (2018) Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology 235:3137\u20133148","journal-title":"Psychopharmacology"},{"key":"269_CR16","doi-asserted-by":"publisher","first-page":"e2020705118","DOI":"10.1073\/pnas.2020705118","volume":"118","author":"D De Gregorio","year":"2021","unstructured":"De Gregorio D, Popic J, Enns JP, Inserra A, Skalecka A, Markopoulos A, Posa L, Lopez-Canul M, Qianzi H, Lafferty CK (2021) Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission. Proc Natl Acad Sci 118:e2020705118","journal-title":"Proc Natl Acad Sci"},{"key":"269_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41386-019-0473-x","volume":"45","author":"H De Wit","year":"2020","unstructured":"De Wit H, Bershad AK (2020) MDMA enhances pleasantness of affective touch. Neuropsychopharmacology 45:217","journal-title":"Neuropsychopharmacology"},{"key":"269_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/17470910802649470","volume":"4","author":"GJ Dumont","year":"2009","unstructured":"Dumont GJ, Sweep F, van der Steen R, Hermsen R, Donders A, Touw DJ, van Gerven J, Buitelaar JK, Verkes R-J (2009) Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3, 4-methylenedioxymethamphetamine) administration. Soc Neurosci 4:359\u2013366","journal-title":"Soc Neurosci"},{"key":"269_CR19","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1016\/j.cub.2018.07.061","volume":"28","author":"E Edsinger","year":"2018","unstructured":"Edsinger E, D\u00f6len G (2018) A conserved role for serotonergic neurotransmission in mediating social behavior in octopus. Curr Biol 28:3136\u20133142.e4","journal-title":"Curr Biol"},{"key":"269_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00213-020-05710-w","volume":"238","author":"AA Feduccia","year":"2021","unstructured":"Feduccia AA, Jerome L, Mithoefer MC, Holland J (2021) Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy. Psychopharmacology 238:581\u2013588","journal-title":"Psychopharmacology"},{"key":"269_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/002076407001600204","volume":"16","author":"G Fisher","year":"1970","unstructured":"Fisher G (1970) The psycholytic treatment of a childhood schizophrenic girl. Int J Soc Psychiatry 16:112\u2013130","journal-title":"Int J Soc Psychiatry"},{"key":"269_CR22","unstructured":"Fisher G, Castile D (1963) Interim report on research project: an investigation to determine therapeutic effectiveness of LSD-25 and psilocybin on hospitalized severely emotionally disturbed children. Unpublished manuscript"},{"key":"269_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1001\/archpsyc.1962.01710210019003","volume":"6","author":"AM Freedman","year":"1962","unstructured":"Freedman AM, Ebin EV, Wilson EA (1962) Autistic schizophrenic children: an experiment in the use of D-lysergic acid diethylamide (LSD-25). Arch Gen Psychiatry 6:203\u2013213","journal-title":"Arch Gen Psychiatry"},{"key":"269_CR24","doi-asserted-by":"publisher","first-page":"7411515430p1","DOI":"10.5014\/ajot.2020.74S1-PO6802","volume":"74","author":"L Green","year":"2020","unstructured":"Green L, Willis E, Ziev N, Oliveira D, Kornblau B, Robertson S (2020) The impact of weighted blankets on the sleep and sensory experiences of autistic adults. Am J Occup Ther 74:7411515430p1","journal-title":"Am J Occup Ther"},{"key":"269_CR25","volume-title":"LSD psychotherapy","author":"S Grof","year":"1980","unstructured":"Grof S (1980) LSD psychotherapy. Hunter House"},{"key":"269_CR26","first-page":"41","volume-title":"Autism spectrum disorders","author":"K Hartmann","year":"2012","unstructured":"Hartmann K, Urbano M, Manser K, Okwara L (2012) Modified dialectical behavior therapy to improve emotion regulation in autism spectrum disorders. In: Autism spectrum disorders. Nova Science Publishers, Hauppauge, pp 41\u201372"},{"key":"269_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40474-018-0133-6","volume":"5","author":"D Hedley","year":"2018","unstructured":"Hedley D, Uljarevi\u0107 M (2018) Systematic review of suicide in autism spectrum disorder: current trends and implications. Curr Dev Disord Rep 5:65\u201376","journal-title":"Curr Dev Disord Rep"},{"key":"269_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1017\/S0033291798007879","volume":"29","author":"RG Heimberg","year":"1999","unstructured":"Heimberg RG, Horner K, Juster H, Safren S, Brown E, Schneier F, Liebowitz M (1999) Psychometric properties of the Liebowitz social anxiety scale. Psychol Med 29:199\u2013212","journal-title":"Psychol Med"},{"key":"269_CR29","first-page":"23","volume":"1","author":"JD Herbert","year":"2002","unstructured":"Herbert JD, Sharp IR, Gaudiano BA (2002) Separating fact from fiction in the etiology and treatment of autism: a scientific review of the evidence. Sci Rev Mental Health Pract 1:23\u201343","journal-title":"Sci Rev Mental Health Pract"},{"key":"269_CR30","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1017\/S0033291718002283","volume":"49","author":"MJ Hollocks","year":"2019","unstructured":"Hollocks MJ, Lerh JW, Magiati I, Meiser-Stedman R, Brugha TS (2019) Anxiety and depression in adults with autism spectrum disorder: a systematic review and meta-analysis. Psychol Med 49:559\u2013572","journal-title":"Psychol Med"},{"key":"269_CR31","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/scan\/nst161","volume":"9","author":"CM Hysek","year":"2014","unstructured":"Hysek CM, Schmid Y, Simmler LD, Domes G, Heinrichs M, Eisenegger C, Preller KH, Quednow BB, Liechti ME (2014) MDMA enhances emotional empathy and prosocial behavior. Soc Cogn Affect Neurosci 9:1645\u20131652","journal-title":"Soc Cogn Affect Neurosci"},{"key":"269_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neubiorev.2015.08.016","volume":"57","author":"P Kamilar-Britt","year":"2015","unstructured":"Kamilar-Britt P, Bedi G (2015) The prosocial effects of 3, 4-methylenedioxymethamphetamine (MDMA): controlled studies in humans and laboratory animals. Neurosci Biobehav Rev 57:433\u2013446","journal-title":"Neurosci Biobehav Rev"},{"key":"269_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mpr.1359","volume":"21","author":"RC Kessler","year":"2012","unstructured":"Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU (2012) Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res 21:169\u2013184","journal-title":"Int J Methods Psychiatr Res"},{"key":"269_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.rasd.2015.04.005","volume":"15","author":"ES Kuschner","year":"2015","unstructured":"Kuschner ES, Eisenberg IW, Orionzi B, Simmons WK, Kenworthy L, Martin A, Wallace GL (2015) A preliminary study of self-reported food selectivity in adolescents and young adults with autism spectrum disorder. Res Autism Spectr Disord 15:53\u201359","journal-title":"Res Autism Spectr Disord"},{"key":"269_CR35","volume-title":"Dialectical behavior therapy in clinical practice","author":"MM Linehan","year":"2020","unstructured":"Linehan MM (2020) Dialectical behavior therapy in clinical practice. Guilford Publications"},{"key":"269_CR36","volume-title":"Managing meltdowns: using the SCARED calming technique with children and adults with autism","author":"D Lipsky","year":"2009","unstructured":"Lipsky D, Richards W (2009) Managing meltdowns: using the SCARED calming technique with children and adults with autism. Jessica Kingsley Publishers"},{"key":"269_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.rasd.2018.03.009","volume":"51","author":"BB Maddox","year":"2018","unstructured":"Maddox BB, Kang-Yi CD, Brodkin ES, Mandell DS (2018) Treatment utilization by adults with autism and co-occurring anxiety or depression. Res Autism Spectr Disord 51:32\u201337","journal-title":"Res Autism Spectr Disord"},{"key":"269_CR38","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","volume":"236","author":"MC Mithoefer","year":"2019","unstructured":"Mithoefer MC, Feduccia AA, Jerome L, Mithoefer A, Wagner M, Walsh Z, Hamilton S, Yazar-Klosinski B, Emerson A, Doblin R (2019) MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology 236:2735\u20132745","journal-title":"Psychopharmacology"},{"key":"269_CR39","first-page":"44","volume":"1","author":"RE Mogar","year":"1969","unstructured":"Mogar RE, Aldrich RW (1969) The use of psychedelic agents with autistic schizophrenic children. Behav Neuropsychiatry 1:44\u201350","journal-title":"Behav Neuropsychiatry"},{"key":"269_CR40","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","volume":"67","author":"FA Moreno","year":"2006","unstructured":"Moreno FA, Wiegand CB, Taitano EK, Delgado PL (2006) Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. J Clin Psychiatry 67:1735\u20131740","journal-title":"J Clin Psychiatry"},{"key":"269_CR41","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.3389\/fpsyg.2018.01196","volume":"9","author":"J Poqu\u00e9russe","year":"2018","unstructured":"Poqu\u00e9russe J, Pastore L, Dellantonio S, Esposito G (2018) Alexithymia and autism spectrum disorder: a complex relationship. Front Psychol 9:1196","journal-title":"Front Psychol"},{"key":"269_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s41252-020-00180-9","volume":"5","author":"J Poqu\u00e9russe","year":"2021","unstructured":"Poqu\u00e9russe J, Pagnini F, Langer EJ (2021) Mindfulness for autism. Adv Neurodev Disord 5:77\u201384","journal-title":"Adv Neurodev Disord"},{"issue":"12","key":"269_CR1002","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","volume":"168","author":"K Posner","year":"2011","unstructured":"Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Mann JJ (2011) The Columbia\u2013suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatr 168(12):1266\u20131277","journal-title":"Am J Psychiatr"},{"key":"269_CR43","doi-asserted-by":"publisher","first-page":"110138","DOI":"10.1016\/j.paid.2020.110138","volume":"166","author":"DA Preece","year":"2020","unstructured":"Preece DA, Becerra R, Allan A, Robinson K, Chen W, Hasking P, Gross JJ (2020) Assessing alexithymia: psychometric properties of the Perth alexithymia questionnaire and 20-item Toronto alexithymia scale in United States adults. Personal Individ Differ 166:110138","journal-title":"Personal Individ Differ"},{"key":"269_CR44","first-page":"497","volume":"6","author":"J Rojas-Berm\u00fadez","year":"1960","unstructured":"Rojas-Berm\u00fadez J (1960) Tratamiento Combinado deo psicoanalisis y LSD 25 en ninos psicoticos [combined treatment with psychoanalysis and LSD 25 in psychotic children]. Acta Neuropsiquait (Argent) 6:497\u2013500","journal-title":"Acta Neuropsiquait (Argent)"},{"issue":"6","key":"269_CR1003","first-page":"552","volume":"1","author":"A Rolo","year":"1965","unstructured":"Rolo A, Krinsky LW, Abramson HA, Goldfarb L (1965) Preliminary method for study of LSD with children. Int J Neuropsychiatr 1(6):552\u2013555","journal-title":"Int J Neuropsychiatr"},{"key":"269_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/13638490601106277","volume":"10","author":"J Sigafoos","year":"2007","unstructured":"Sigafoos J, Green VA, Edrisinha C, Lancioni GE (2007) Flashback to the 1960s: LSD in the treatment of autism. Dev Neurorehabil 10:75\u201381","journal-title":"Dev Neurorehabil"},{"key":"269_CR46","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1176\/ajp.122.11.1201","volume":"122","author":"J Simmons 3rd","year":"1966","unstructured":"Simmons J 3rd, Leiken S, Lovaas O, Schaeffer B, Perloff B (1966) Modification of autistic behavior with LSD-25. Am J Psychiatry 122:1201\u20131211","journal-title":"Am J Psychiatry"},{"key":"269_CR47","first-page":"10-6 passim","volume":"4","author":"J Simmons","year":"1972","unstructured":"Simmons J, Benor D, Daniel D (1972) The variable effects of LSD-25 on the behavior of a heterogeneous group of childhood schizophrenics. Behav Neuropsychiatry 4:10-6 passim","journal-title":"Behav Neuropsychiatry"},{"key":"269_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.rasd.2018.04.007","volume":"52","author":"D Spain","year":"2018","unstructured":"Spain D, Sin J, Linder KB, Mcmahon J, Happ\u00e9 F (2018) Social anxiety in autism spectrum disorder: a systematic review. Res Autism Spectr Disord 52:51\u201368","journal-title":"Res Autism Spectr Disord"},{"key":"269_CR49","doi-asserted-by":"publisher","DOI":"10.1177\/1362361320913192","volume-title":"Both sex-and gender-related factors should be considered in autism research and clinical practice","author":"JF Strang","year":"2020","unstructured":"Strang JF, van der Miesen AI, Caplan R, Hughes C, Davanport S, Lai M-C (2020) Both sex-and gender-related factors should be considered in autism research and clinical practice. SAGE, London"},{"key":"269_CR50","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00005053-199503000-00002","volume":"183","author":"RJ Strassman","year":"1995","unstructured":"Strassman RJ (1995) Hallucinogenic drugs in psychiatric research and treatment: perspectives and prospects. J Nerv Ment Dis 183:127\u2013138","journal-title":"J Nerv Ment Dis"},{"key":"269_CR51","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1177\/0269881121998322","volume":"35","author":"E Studerus","year":"2021","unstructured":"Studerus E, Vizeli P, Harder S, Ley L, Liechti ME (2021) Prediction of MDMA response in healthy humans: a pooled analysis of placebo-controlled studies. J Psychopharmacol 35:556\u2013565","journal-title":"J Psychopharmacol"},{"key":"269_CR52","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/978-3-030-30402-7_14","volume":"24","author":"T Sumathi","year":"2020","unstructured":"Sumathi T, Manivasagam T, Thenmozhi AJ (2020) The role of gluten in autism. Adv Neurobiol 24:469\u2013479","journal-title":"Adv Neurobiol"},{"key":"269_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/1362361300004001004","volume":"4","author":"D Tantam","year":"2000","unstructured":"Tantam D (2000) Psychological disorder in adolescents and adults with Asperger syndrome. Autism 4:47\u201362","journal-title":"Autism"},{"issue":"1","key":"269_CR54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1056-4993(02)00053-6","volume":"12","author":"D Tantam","year":"2003","unstructured":"Tantam D (2003) The challenge of adolescents and adults with Asperger syndromes. Child Adolesc Psychiatr Clin N Am 12(1):143\u2013163","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"269_CR55","first-page":"136","volume-title":"Manifesting minds: a review of psychedelics in science, medicine, sex, and spirituality","author":"K Taylor","year":"2014","unstructured":"Taylor K (2014) Ethical caring in psychedelic work. In: Manifesting minds: a review of psychedelics in science, medicine, sex, and spirituality. Evolver Editions, Berkeley, p 136"},{"key":"269_CR56","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/10883576070220030101","volume":"22","author":"LY Tsai","year":"2007","unstructured":"Tsai LY (2007) Asperger syndrome and medication treatment. Focus Autism Other Dev Disabil 22:138\u2013148","journal-title":"Focus Autism Other Dev Disabil"},{"key":"269_CR57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1001\/jamapsychiatry.2018.3645","volume":"76","author":"T Velikonja","year":"2019","unstructured":"Velikonja T, Fett A-K, Velthorst E (2019) Patterns of nonsocial and social cognitive functioning in adults with autism spectrum disorder: a systematic review and meta-analysis. JAMA Psychiat 76:135\u2013151","journal-title":"JAMA Psychiat"},{"key":"269_CR58","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1007\/s00213-017-4684-8","volume":"234","author":"MB Young","year":"2017","unstructured":"Young MB, Norrholm SD, Khoury LM, Jovanovic T, Rauch SA, Reiff CM, Dunlop BW, Rothbaum BO, Howell LL (2017) Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3, 4-methylenedioxymethamphetamine (MDMA). Psychopharmacology 234:2883\u20132895","journal-title":"Psychopharmacology"}],"container-title":["Current Topics in Behavioral Neurosciences","Disruptive Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2021_269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T20:05:43Z","timestamp":1661457943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2021_269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783031121838","9783031121845"],"references-count":61,"URL":"https:\/\/doi.org\/10.1007\/7854_2021_269","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"11 November 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}